Pfizer CSO Mikael Dolsten to Step Down After 15 Years Driving R&D

Pfizer announced Tuesday that Chief Science Officer Mikael Dolsten is stepping down after more than 15 years leading the pharma giant’s research and development efforts.

Dolsten joined Pfizer with the 2009 acquisition of Wyeth as president of worldwide R&D.